King of Prussia, PA, United States of America

Michelle Spatara

This inventor holds 9 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Glaxosmithkline Intellectual Property (No.2) Limited. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michelle Spatara. Retrieved from https://idiyas.com/inventor/michelle-spatara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 2)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 20(Granted Patents)

Company Filing History:

9 out of 95

Glaxosmithkline Intellectual Property (No.2) Limited

patents

Years Active: 2020-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12454571 - Biopharmaceutical compositions (2025-10-28),

2. 12187791 - Biopharmaceutical compositions (2025-01-07),

3. 12187790 - Biopharmaceutical compositions (2025-01-07),

4. 12187789 - Biopharmaceutical compositions (2025-01-07),

5. 11459384 - Biopharmaceutical compositions (2022-10-04),

6. 11299541 - Biopharmaceutical compositions (2022-04-12),

7. 11286298 - Biopharmaceutical compositions (2022-03-29),

8. 11274148 - Biopharmaceutical compositions (2022-03-15),

9. 10870695 - Biopharmaceutical compositions comprising interleukin-5 antibody (2020-12-22),

Title: The Innovations of Inventor Michelle Spatara

Introduction

Michelle Spatara, an accomplished inventor based in King of Prussia, Pennsylvania, has made significant contributions to the field of biopharmaceuticals. With a portfolio of eight patents, she has dedicated her career to advancing medical technology and improving treatment options for various diseases.

Latest Patents

Among her most recent innovations are groundbreaking biopharmaceutical compositions aimed at treating interleukin 5 (IL-5) mediated diseases. These compositions and related methods demonstrate her commitment to addressing complex health challenges through innovative solutions.

Career Highlights

Michelle is currently associated with GlaxoSmithKline Intellectual Property (No. 2) Limited, where her expertise is instrumental in the development of novel medical therapies. Throughout her career, she has consistently focused on translating scientific research into practical applications that benefit patients worldwide.

Collaborations

In her journey, Michelle has collaborated with notable colleagues such as Myrna A. Monck and Narendra B. Bam. These partnerships have facilitated the exchange of ideas and propelled the development of innovative treatments, showcasing the power of teamwork in driving scientific progress.

Conclusion

With her impressive track record and unwavering commitment to innovation, Michelle Spatara stands out as a key figure in the realm of biopharmaceutical research. Her contributions promise to enhance therapeutic options and improve the quality of life for many individuals affected by IL-5 mediated diseases.

Profile summary based on public USPTO records.